DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

AGOS Co., Ltd.

KOSDAQ:A175140 Stock Report

Market Cap: ₩62.6b

  • Company Overview
  • Valuation
  • Future Growth
  • Past Performance
  • Financial Health
  • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

AGOS Balance Sheet Health

Financial Health criteria checks 6/6

AGOS has a total shareholder equity of ₩39.9B and total debt of ₩4.1B, which brings its debt-to-equity ratio to 10.3%. Its total assets and total liabilities are ₩58.6B and ₩18.8B respectively.

Key information

10.34%

Debt to equity ratio

₩4.12b

Debt

Interest coverage ration/a
Cash₩14.69b
Equity₩39.85b
Total liabilities₩18.78b
Total assets₩58.63b

Recent financial health updates

Analysis Article • Dec 22

Is HUMAN TECHNOLOGY (KOSDAQ:175140) Using Debt Sensibly?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Jun 13

Is HUMAN TECHNOLOGY (KOSDAQ:175140) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Jan 24

HUMAN TECHNOLOGY (KOSDAQ:175140) Is Using Debt Safely

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Oct 15

HUMAN TECHNOLOGY (KOSDAQ:175140) Has Debt But No Earnings; Should You Worry?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Dec 24

Does Infomark (KOSDAQ:175140) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Recent updates

Analysis Article • Feb 02

HUMAN TECHNOLOGY Co., Ltd's (KOSDAQ:175140) Share Price Not Quite Adding Up

When close to half the companies in the Communications industry in Korea have price-to-sales ratios (or "P/S") below...
Analysis Article • Dec 22

Is HUMAN TECHNOLOGY (KOSDAQ:175140) Using Debt Sensibly?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Aug 23

Risks Still Elevated At These Prices As HUMAN TECHNOLOGY Co., Ltd (KOSDAQ:175140) Shares Dive 29%

HUMAN TECHNOLOGY Co., Ltd ( KOSDAQ:175140 ) shareholders won't be pleased to see that the share price has had a very...
Analysis Article • Jun 16

What HUMAN TECHNOLOGY Co., Ltd's (KOSDAQ:175140) 25% Share Price Gain Is Not Telling You

HUMAN TECHNOLOGY Co., Ltd ( KOSDAQ:175140 ) shares have had a really impressive month, gaining 25% after a shaky period...
Analysis Article • Jun 13

Is HUMAN TECHNOLOGY (KOSDAQ:175140) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Apr 06

Some HUMAN TECHNOLOGY Co., Ltd (KOSDAQ:175140) Shareholders Look For Exit As Shares Take 25% Pounding

HUMAN TECHNOLOGY Co., Ltd ( KOSDAQ:175140 ) shareholders won't be pleased to see that the share price has had a very...
Analysis Article • Jan 24

HUMAN TECHNOLOGY (KOSDAQ:175140) Is Using Debt Safely

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article • Nov 27

Subdued Growth No Barrier To HUMAN TECHNOLOGY Co., Ltd (KOSDAQ:175140) With Shares Advancing 25%

HUMAN TECHNOLOGY Co., Ltd ( KOSDAQ:175140 ) shareholders are no doubt pleased to see that the share price has bounced...
Analysis Article • Oct 15

HUMAN TECHNOLOGY (KOSDAQ:175140) Has Debt But No Earnings; Should You Worry?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Aug 06

Subdued Growth No Barrier To HUMAN TECHNOLOGY Co., Ltd's (KOSDAQ:175140) Price

When close to half the companies in the Communications industry in Korea have price-to-sales ratios (or "P/S") below...
Analysis Article • Dec 24

Does Infomark (KOSDAQ:175140) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Financial Position Analysis

Short Term Liabilities: A175140's short term assets (₩28.7B) exceed its short term liabilities (₩16.2B).

Long Term Liabilities: A175140's short term assets (₩28.7B) exceed its long term liabilities (₩2.6B).


Debt to Equity History and Analysis

Debt Level: A175140 has more cash than its total debt.

Reducing Debt: A175140's debt to equity ratio has reduced from 101.7% to 10.3% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable A175140 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: A175140 is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 26.3% per year.


Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/10 21:40
End of Day Share Price 2026/09/10 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AGOS Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jongsun ParkEugene Investment & Securities Co Ltd.
Juho YoonYuanta Securities Korea Co., Ltd.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide